Benzodiazepine Drugs Market, by Product (Long Acting Benzodiazepine {Chlordiazepoxide, Diazepam, Lorazepam, Alprazolam, Clonazepam, and Others}, Short Acting Benzodiazepine {Temazepam, Midazolam, Triazolam and Others), by Application (Anxiety Disorders, N

Benzodiazepine Drugs Market, by Product (Long Acting Benzodiazepine {Chlordiazepoxide, Diazepam, Lorazepam, Alprazolam, Clonazepam, and Others}, Short Acting Benzodiazepine {Temazepam, Midazolam, Triazolam and Others), by Application (Anxiety Disorders, Nervousness, Sedation, Seizures, Alcohol Withdrawal and Others), by Route of Administration (Oral, Injectables, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Benzodiazepines are a group of prescription-only medicines that have a sedating/hypnotic and calming effects on the nervous system. Some of the examples of benzodiazepines that are used for the treatment of anxiety, seizures, etc. are diazepam, lorazepam, oxazepam, temazepam, and alprazolam. Most of the benzodiazepine drugs are available as generics as most of the patent are expired. The benzodiazepine are still widely recognizable under brand names such as Valium or Xanax. They come in the form of tablet and capsule forms and some are available for intravenous forms to be used in hospital settings.

Market Dynamics

Market players are engaged in facility expansion, in order to expand its manufacturing facility and product portfolio. This is expected to drive growth of the global benzodiazepine drugs market over the forecast period. For instance, in January 2018, Torrent Pharmaceuticals Ltd. acquired Bio-Pharm, Inc., a U.S.-based generic pharmaceuticals and over-the-counter (OTC) Company which also included a U.S. Food and Drug Administration (FDA) registered 75,000 sqft manufacturing facility in the U.S.

Key players are engaged in receiving approval for their products from the regulatory authorities. This is expected to drive growth of the market over the forecast period. For instance, in October 2018, Amneal Pharmaceuticals, Inc., an American biopharmaceutical company announced that a generic version of Onfi (clobazam) tablets, 10 mg and 20 mg for oral use, CIV, and Onfi (clobazam) oral suspension, 2.5 mg/mL, CIV, has been approved by the U.S. Food and Drugs Administration.

Key features of the study:
This report provides an in-depth analysis of the global benzodiazepine drugs market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2022-2030), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
It profiles leading players in the global benzodiazepine drugs market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as a part of this study include F.Hoffmann-La Roche Ltd., Torrent Pharmaceuticals Ltd., Mallinckrodt Pharmaceuticals, Pfizer Inc., Viatris Inc. (Mylan N.V.), Labiana Pharmaceuticals, Bausch Health Companies, Inc., Teva Pharmaceutical Industries Ltd., Amneal Pharmaceuticals LLC, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, Par Pharmaceutical, and Intas Pharmaceuticals Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
The global benzodiazepine drugs market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global benzodiazepine drugs market
Detailed Segmentation:
Global Benzodiazepine Drugs Market, By Product:
Long Acting Benzodiazepine
Chlordiazepoxide
Diazepam
Lorazepam
Alprazolam
Clonazepam
Others
Short Acting Benzodiazepine
Temazepam
Midazolam
Triazolam
Others
Global Benzodiazepine Drugs Market, By Application:
Anxiety Disorders
Nervousness
Sedation
Seizures
Alcohol Withdrawal
Others
Global Benzodiazepine Drugs Market, By Route of Administration:
Oral
Injectables
Others
Global Benzodiazepine Drugs Market, By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Benzodiazepine Drugs Market, By Region:
North America
By Product:
Long Acting Benzodiazepine
Chlordiazepoxide
Diazepam
Lorazepam
Alprazolam
Clonazepam
Others
Short Acting Benzodiazepine
Temazepam
Midazolam
Triazolam
Others
By Application:
Anxiety Disorders
Nervousness
Sedation
Seizures
Alcohol Withdrawal
Others
By Route of Administration:
Oral
Injectables
Others
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
U.S.
Canada
Latin America
By Product:
Long Acting Benzodiazepine
Chlordiazepoxide
Diazepam
Lorazepam
Alprazolam
Clonazepam
Others
Short Acting Benzodiazepine
Temazepam
Midazolam
Triazolam
Others
By Application:
Anxiety Disorders
Nervousness
Sedation
Seizures
Alcohol Withdrawal
Others
By Route of Administration:
Oral
Injectables
Others
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
ICU’s
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Product:
Long Acting Benzodiazepine
Chlordiazepoxide
Diazepam
Lorazepam
Alprazolam
Clonazepam
Others
Short Acting Benzodiazepine
Temazepam
Midazolam
Triazolam
Others
By Application:
Anxiety Disorders
Nervousness
Sedation
Seizures
Alcohol Withdrawal
Others
By Route of Administration:
Oral
Injectables
Others
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe
Asia Pacific
By Product:
Long Acting Benzodiazepine
Chlordiazepoxide
Diazepam
Lorazepam
Alprazolam
Clonazepam
Others
Short Acting Benzodiazepine
Temazepam
Midazolam
Triazolam
Others
By Application:
Anxiety Disorders
Nervousness
Sedation
Seizures
Alcohol Withdrawal
Others
By Route of Administration:
Oral
Injectables
Others
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
Australia
India
China
Japan
ASEAN
South Korea
Rest of Asia Pacific
Middle East
By Product:
Long Acting Benzodiazepine
Chlordiazepoxide
Diazepam
Lorazepam
Alprazolam
Clonazepam
Others
Short Acting Benzodiazepine
Temazepam
Midazolam
Triazolam
Others
By Application:
Anxiety Disorders
Nervousness
Sedation
Seizures
Alcohol Withdrawal
Others
By Route of Administration:
Oral
Injectables
Others
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
GCC
Israel
Rest of Middle East
Africa
By Product:
Long Acting Benzodiazepine
Chlordiazepoxide
Diazepam
Lorazepam
Alprazolam
Clonazepam
Others
Short Acting Benzodiazepine
Temazepam
Midazolam
Triazolam
Others
By Application:
Anxiety Disorders
Nervousness
Sedation
Seizures
Alcohol Withdrawal
Others
By Route of Administration:
Oral
Injectables
Others
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country/Region:
South Africa
Central Africa
North Africa
Company Profiles
F.Hoffmann-La Roche Ltd.*
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Torrent Pharmaceuticals Ltd.
Mallinckrodt Pharmaceuticals
Pfizer Inc.
Viatris Inc. (Mylan N.V.)
Labiana Pharmaceuticals
Bausch Health Companies, Inc.
Teva Pharmaceutical Industries Ltd.,
Amneal Pharmaceuticals LLC
Sun Pharmaceutical Industries Ltd.
Aurobindo Pharma
Par Pharmaceutical
Intas Pharmaceuticals Ltd
“*” marked represents similar segmentation in other categories in the respective section.